by Samantha Liss, KFF Health News Credit: Unsplash/CC0 Public Domain Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country. The issue is that some insurers are bypassing hospital pharmacies and physician offices and instead sending more complex drugs...
